IL140698A0 - Immunological reagent specifically interacting with the extracellular domain of the human zeta chain - Google Patents
Immunological reagent specifically interacting with the extracellular domain of the human zeta chainInfo
- Publication number
- IL140698A0 IL140698A0 IL14069899A IL14069899A IL140698A0 IL 140698 A0 IL140698 A0 IL 140698A0 IL 14069899 A IL14069899 A IL 14069899A IL 14069899 A IL14069899 A IL 14069899A IL 140698 A0 IL140698 A0 IL 140698A0
- Authority
- IL
- Israel
- Prior art keywords
- antibody
- chain
- nucleic acid
- extracellular domain
- zeta
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 210000000822 natural killer cell Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98112867 | 1998-07-10 | ||
| PCT/EP1999/004838 WO2000003016A1 (en) | 1998-07-10 | 1999-07-09 | Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140698A0 true IL140698A0 (en) | 2002-02-10 |
Family
ID=8232256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14069899A IL140698A0 (en) | 1998-07-10 | 1999-07-09 | Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20050163770A1 (pt) |
| EP (1) | EP1097210B1 (pt) |
| JP (1) | JP2002520021A (pt) |
| KR (1) | KR20010074697A (pt) |
| CN (1) | CN1230538C (pt) |
| AT (1) | ATE330012T1 (pt) |
| AU (1) | AU767443B2 (pt) |
| CA (1) | CA2335090A1 (pt) |
| DE (1) | DE69931926T2 (pt) |
| ES (1) | ES2267275T3 (pt) |
| ID (1) | ID28117A (pt) |
| IL (1) | IL140698A0 (pt) |
| NO (1) | NO20010148L (pt) |
| NZ (1) | NZ509232A (pt) |
| PT (1) | PT1097210E (pt) |
| TR (1) | TR200100039T2 (pt) |
| WO (1) | WO2000003016A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004084931A1 (en) * | 2003-03-24 | 2004-10-07 | Tap Pharmaceuticals Products Inc. | Use of chemokine receptor agonists for stem cell transplantation |
| US7919089B2 (en) | 2003-05-31 | 2011-04-05 | Micromet Ag | Pharmaceutical composition comprising a bispecific antibody for EpCAM |
| AU2015280436A1 (en) | 2014-06-23 | 2017-02-02 | Bionomics, Inc. | Antibodies that bind LGR4 |
| TW201829463A (zh) | 2016-11-18 | 2018-08-16 | 瑞士商赫孚孟拉羅股份公司 | 抗hla-g抗體及其用途 |
| CN111808183B (zh) * | 2020-07-25 | 2022-07-08 | 北京吉尔麦迪生物医药科技有限公司 | 一种靶向CD47的高亲和力SIRPα突变体及其融合蛋白 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260203A (en) * | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| WO1990015822A1 (en) * | 1989-06-15 | 1990-12-27 | Dana-Farber Cancer Institute | Monoclonal antibody to intracellular epitope of human t cell receptor zeta chain and method of preparation |
| UA40577C2 (uk) * | 1993-08-02 | 2001-08-15 | Мерк Патент Гмбх | Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин |
-
1999
- 1999-07-09 TR TR2001/00039T patent/TR200100039T2/xx unknown
- 1999-07-09 DE DE69931926T patent/DE69931926T2/de not_active Expired - Fee Related
- 1999-07-09 PT PT99932859T patent/PT1097210E/pt unknown
- 1999-07-09 KR KR1020017000441A patent/KR20010074697A/ko not_active Application Discontinuation
- 1999-07-09 CN CNB998083828A patent/CN1230538C/zh not_active Expired - Fee Related
- 1999-07-09 NZ NZ509232A patent/NZ509232A/en unknown
- 1999-07-09 JP JP2000559237A patent/JP2002520021A/ja not_active Withdrawn
- 1999-07-09 CA CA002335090A patent/CA2335090A1/en not_active Abandoned
- 1999-07-09 ID IDW20010029A patent/ID28117A/id unknown
- 1999-07-09 AU AU49091/99A patent/AU767443B2/en not_active Ceased
- 1999-07-09 WO PCT/EP1999/004838 patent/WO2000003016A1/en not_active Application Discontinuation
- 1999-07-09 IL IL14069899A patent/IL140698A0/xx unknown
- 1999-07-09 AT AT99932859T patent/ATE330012T1/de not_active IP Right Cessation
- 1999-07-09 ES ES99932859T patent/ES2267275T3/es not_active Expired - Lifetime
- 1999-07-09 EP EP99932859A patent/EP1097210B1/en not_active Expired - Lifetime
-
2001
- 2001-01-09 NO NO20010148A patent/NO20010148L/no not_active Application Discontinuation
-
2005
- 2005-01-18 US US11/036,098 patent/US20050163770A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000003016A1 (en) | 2000-01-20 |
| EP1097210B1 (en) | 2006-06-14 |
| ID28117A (id) | 2001-05-03 |
| KR20010074697A (ko) | 2001-08-09 |
| DE69931926D1 (de) | 2006-07-27 |
| NO20010148D0 (no) | 2001-01-09 |
| NO20010148L (no) | 2001-03-09 |
| AU4909199A (en) | 2000-02-01 |
| US20050163770A1 (en) | 2005-07-28 |
| PT1097210E (pt) | 2006-09-29 |
| CA2335090A1 (en) | 2000-01-20 |
| TR200100039T2 (tr) | 2001-05-21 |
| AU767443B2 (en) | 2003-11-13 |
| DE69931926T2 (de) | 2007-02-01 |
| NZ509232A (en) | 2003-10-31 |
| ATE330012T1 (de) | 2006-07-15 |
| EP1097210A1 (en) | 2001-05-09 |
| JP2002520021A (ja) | 2002-07-09 |
| CN1230538C (zh) | 2005-12-07 |
| ES2267275T3 (es) | 2007-03-01 |
| CN1308675A (zh) | 2001-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA40621C2 (uk) | Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла | |
| SG156547A1 (en) | Human monoclonal antibodies to ctla-4 | |
| WO1994029350A3 (en) | Recombinant disulfide-stabilized polypeptide fragments having binding specificity | |
| WO1998050433A3 (en) | Human monoclonal antibodies to epidermal growth factor receptor | |
| HRP20050986A2 (en) | Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof | |
| EP2829549A3 (en) | Hybrid and tandem expression of neisserial derived proteins | |
| WO2006050949A3 (de) | Superagonistische anti-cd28 antikörper | |
| TW200634027A (en) | Antibodies directed to angiopoietin-2 and uses thereof | |
| WO2006055704A3 (en) | Antibodies directed to ten-m proteins and uses thereof | |
| RS51829B (sr) | Ljudska antitela specifična za interleukin 15 (il-15) | |
| CA2130452A1 (en) | Altered antibodies, products and processes relating thereto | |
| UA83791C2 (ru) | Антитело против vla-1, фармацевтическая композиция, которая его содержит, и из применение для лечения индивидуума с иммунологическим расстройством, опосредованным vla-1 | |
| NZ602780A (en) | Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof | |
| WO2000024884A3 (en) | Antigen-binding proteins comprising a linker which confers restricted conformational flexibility | |
| WO2003025015A3 (en) | A soluble toll-like receptor | |
| IL140698A0 (en) | Immunological reagent specifically interacting with the extracellular domain of the human zeta chain | |
| CA2441187A1 (en) | Acetyllysine-recognizing monoclonal antibody and process for producing the same | |
| Smith-Gill et al. | Contribution of the VK4 light chain to antibody specificity for lysozyme and β (1, 6) d-galactan | |
| WO2003051913A3 (en) | Antigens for actinobacillus pleuropneumoniae and methods thereof | |
| RU2422528C2 (ru) | Днк, кодирующая модифицированное антитело или соединение с активностью агониста тро, способ их получения и животная клетка или микроорганизм, их продуцирующие | |
| WO2003025143A3 (en) | Maxp1 | |
| HUP9902713A2 (hu) | Ráksejteket specifikusan detektáló antigénkötő fragmensek, a fragmenseket kódoló nukleotidok és alkalmazásuk rák megelőzésére, és kimutatására |